IL6R and neoplasm: Indeed, upregulation of ADAM17 and downregulation of mIL-6R were observed in a colon cancer model [73] and in colon cancer patients [79], leading to increased cleavage of the mIL-6R and release of the sIL-6R from the tumor cells.